NovoCure Ltd Insider Trading for January 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovoCure Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NovoCure Ltd for January 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31 2018 | NVCR | Novocure Ltd | Longsworth Todd Christopher | General Counsel | Option Exercise | M | 6.72 | 11,630 | 78,154 | 71,152 | |
| Jan 31 2018 | NVCR | Novocure Ltd | Longsworth Todd Christopher | General Counsel | Sell | S | 24.00 | 11,630 | 279,120 | 4,998 | 16.6 K to 5 K (-69.94 %) |
| Jan 31 2018 | NVCR | Novocure Ltd | Longsworth Todd Christopher | General Counsel | Buy | M | 6.72 | 11,630 | 78,154 | 16,628 | 5 K to 16.6 K (+232.69 %) |
| Jan 31 2018 | NVCR | Novocure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 24.02 | 13,974 | 335,588 | 356,790 | 370.8 K to 356.8 K (-3.77 %) |
| Jan 26 2018 | NVCR | Novocure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 22.43 | 6,456 | 144,840 | 370,764 | 377.2 K to 370.8 K (-1.71 %) |
| Jan 25 2018 | NVCR | Novocure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 22.17 | 10,600 | 235,007 | 377,220 | 387.8 K to 377.2 K (-2.73 %) |
| Jan 25 2018 | NVCR | Novocure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 22.03 | 10,248 | 225,794 | 387,820 | 398.1 K to 387.8 K (-2.57 %) |
| Jan 24 2018 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | M | 3.59 | 1,549 | 5,561 | 0 | |
| Jan 24 2018 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | M | 3.59 | 1,549 | 5,561 | 92,746 | 91.2 K to 92.7 K (+1.70 %) |
| Jan 17 2018 | NVCR | Novocure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 22.20 | 14,900 | 330,755 | 398,068 | 413 K to 398.1 K (-3.61 %) |
| Jan 16 2018 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 22.00 | 25,320 | 557,126 | 3,181 | 28.5 K to 3.2 K (-88.84 %) |
| Jan 16 2018 | NVCR | Novocure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 22.02 | 22,895 | 504,237 | 412,968 | 435.9 K to 413 K (-5.25 %) |
| Jan 16 2018 | NVCR | Novocure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 22.35 | 313,525 | 7,007,503 | 435,863 | 749.4 K to 435.9 K (-41.84 %) |
| Jan 10 2018 | NVCR | Novocure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 21.02 | 31,132 | 654,376 | 209,078 | 240.2 K to 209.1 K (-12.96 %) |
| Jan 10 2018 | NVCR | Novocure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Grant | A | 15.05 | 310 | 4,664 | 240,210 | 239.9 K to 240.2 K (+0.13 %) |
| Jan 10 2018 | NVCR | Novocure Ltd | Longsworth Todd Christopher | General Counsel | Grant | A | 15.05 | 166 | 2,497 | 4,998 | 4.8 K to 5 K (+3.44 %) |
| Jan 10 2018 | NVCR | Novocure Ltd | Danziger Asaf | Chief Executive Off ... | Grant | A | 15.05 | 283 | 4,258 | 749,388 | 749.1 K to 749.4 K (+0.04 %) |
| Jan 05 2018 | NVCR | Novocure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 21.03 | 26,264 | 552,314 | 239,900 | 266.2 K to 239.9 K (-9.87 %) |
| Jan 05 2018 | NVCR | Novocure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 21.00 | 2,404 | 50,484 | 266,164 | 268.6 K to 266.2 K (-0.90 %) |
| Jan 05 2018 | NVCR | Novocure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 21.03 | 200 | 4,205 | 268,568 | 268.8 K to 268.6 K (-0.07 %) |